Cardiac soluble guanylate cyclase protects against the cardiac dysfunction induced by chronic doxorubicin treatment in mice

Vandenwijngaert, SaraSwinnen, MelissaGillijns, HildeCaluwé, EllenTainsh, Robert ENathan, Daniel IAllen, KaitlinBartunek, JozefBrouckaert, PeterScherrer-Crosbie, MarielleBloch, Kenneth DJanssens, Stefan PBuys, Emmanuel2015-10-012015Vandenwijngaert, S., M. Swinnen, H. Gillijns, E. Caluwé, R. E. Tainsh, D. I. Nathan, K. Allen, et al. 2015. “Cardiac soluble guanylate cyclase protects against the cardiac dysfunction induced by chronic doxorubicin treatment in mice.” BMC Pharmacology & Toxicology 16 (Suppl 1): A96. doi:10.1186/2050-6511-16-S1-A96. http://dx.doi.org/10.1186/2050-6511-16-S1-A96.2050-6511http://nrs.harvard.edu/urn-3:HUL.InstRepos:22856932en-USCardiac soluble guanylate cyclase protects against the cardiac dysfunction induced by chronic doxorubicin treatment in miceJournal Article2015-10-0110.1186/2050-6511-16-S1-A96